The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease

[1]  R. Frye,et al.  T-Cell–Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes , 2002, Circulation.

[2]  G. Hansson,et al.  Nuclear factor kappa-B and the heart. , 2001, Journal of the American College of Cardiology.

[3]  S. Blankenberg,et al.  Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease , 2001, Circulation.

[4]  A. Kastrati,et al.  Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial , 2001, The Lancet.

[5]  S. Blankenberg,et al.  Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease , 2001, Circulation.

[6]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[7]  K. Ley,et al.  VCAM-1 is critical in atherosclerosis. , 2001, The Journal of clinical investigation.

[8]  Paul M. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[9]  Peter Søgaard,et al.  Electromechanical Mapping for Detection of Myocardial Viability in Patients With Ischemic Cardiomyopathy , 2001, Circulation.

[10]  V. Hombach,et al.  C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis , 2001, Circulation.

[11]  P. Mcgeer,et al.  Generation of C-reactive protein and complement components in atherosclerotic plaques. , 2001, The American journal of pathology.

[12]  Qingbo Xu,et al.  Chronic Infections and the Risk of Carotid Atherosclerosis Prospective Results From a Large Population Study , 2001 .

[13]  L. Ferrucci,et al.  Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: The Women’s Health and Aging Study , 2001, Circulation.

[14]  P. Ridker,et al.  Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. , 2001, Journal of the American College of Cardiology.

[15]  B. Horne,et al.  Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death , 2001, Circulation.

[16]  M. Naghavi,et al.  Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction , 2000, Circulation.

[17]  R. Kronmal,et al.  Chlamydia pneumoniae, Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults: The Cardiovascular Health Study , 2000, Circulation.

[18]  James T. Willerson,et al.  Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.

[19]  D. Rader.  Inflammatory markers of coronary risk. , 2000, The New England journal of medicine.

[20]  B. Horne,et al.  Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease , 2000, Circulation.

[21]  B. Horne,et al.  Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study , 2000, Circulation.

[22]  J. Volanakis,et al.  Human C-Reactive Protein Is Protective against Fatal Salmonella enterica Serovar Typhimurium Infection in Transgenic Mice , 2000, Infection and Immunity.

[23]  W. Koenig,et al.  C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[24]  P. Vallance,et al.  Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. , 2000, Circulation.

[25]  J. Mehta,et al.  Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. , 2000, Circulation.

[26]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[27]  M. Leinonen,et al.  Infections, inflammation, and the risk of coronary heart disease. , 2000, Circulation.

[28]  A. Quyyumi,et al.  Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. , 2000, The American journal of cardiology.

[29]  Philip Greenland,et al.  Prevention Conference V Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Executive Summary , 2000 .

[30]  M. Pepys,et al.  C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.

[31]  J. Danesh.  Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. , 1999, American heart journal.

[32]  B. Chiu.  Multiple infections in carotid atherosclerotic plaques. , 1999, American heart journal.

[33]  G. Byrne,et al.  Chlamydia pneumoniae and atherosclerosis: links to the disease process. , 1999, American heart journal.

[34]  F. Nieto.  Viruses and atherosclerosis: a critical review of the epidemiologic evidence. , 1999, American heart journal.

[35]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[36]  M. Rosenfeld,et al.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. , 1999, The Journal of infectious diseases.

[37]  W. Koenig.  Fibrinogen and coronary risk , 1999, Current cardiology reports.

[38]  R Peto,et al.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.

[39]  P. Libby,et al.  CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.

[40]  J. Carlquist,et al.  Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. , 1998, Circulation.

[41]  P. Libby,et al.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.

[42]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[43]  C. Visser,et al.  C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. , 1997, Circulation.

[44]  I. T. Ten Berge,et al.  CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. , 1996, Journal of immunology.

[45]  M L Woods,et al.  Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. , 1996, Journal of the American College of Cardiology.

[46]  P. Libby.  Molecular bases of the acute coronary syndromes. , 1995, Circulation.

[47]  Grayston Jt.  Infections caused by Chlamydia pneumoniae strain TWAR. , 1992 .

[48]  S. Blankenberg,et al.  Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis , 2002, Circulation.

[49]  Ridker Pm.  Novel risk factors and markers for coronary disease. , 2000 .